[Company Profile] Echo Therapeutics
Echo Therapeutics of Franklin, Mass., has developed the Symphony tCGM System, a needle-free, wireless system that allows patients to painlessly and accurately monitor their blood glucose levels around the clock.
Articles by vanderson
Researchers Identify Lupus Trigger
Researchers identified three proteins, called Toll-Like Receptors (TLRs), that can cause the immune system to turn against the body.
CombinatoRx to Merge with Neuromed
CombinatoRx has signed an all-stock merger agreement with Neuromed.
Cynosure, Unilever Join Forces to Develop Home-Use Aesthetic Devices
The multi-year agreement will focus on the skin rejuvenation segment of the marketplace.
AST to Resume Clinical Trials of Spinal Stabilization Device
Applied Spine Technologies has received permission from the FDA to restart a clinical trial of Stabilimax NZ.
BioGlue Used In Over Half a Million Surgeries
CryoLife’s BioGlue Surgical Adhesive has been used in more than 500,000 surgical procedures worldwide since its introduction in 1998.
Promising Genetic Biomarker Identified for Colorectal Cancer
A new genetic discovery could lead to easier detection of colorectal cancer.
Electro-Optical Submits MelaFind for Premarket Approval
Electro-Optical Sciences anounced that it has submitted a Premarket Approval Application to the U.S. Food and Drug Administration for MelaFind.
SyntheMed’s REPEL-CV Approved by Australian Regulators
REPEL-CV, an anti-adhesion barrier developed by biomaterials company SyntheMed, has received approval by the Australian Therapeutic Goods Administration for use in open-heart surgery.
OneMedPlace at 2009 BIO International Convention
OneMedPlace will be covering the 2009 BIO International Convention, the largest biotechnology event in the world. The BIO International Convention attracts the biggest names in biotech, […]